Hiroaki Semba

1.4k total citations
45 papers, 531 citations indexed

About

Hiroaki Semba is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Complementary and alternative medicine. According to data from OpenAlex, Hiroaki Semba has authored 45 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 6 papers in Complementary and alternative medicine. Recurrent topics in Hiroaki Semba's work include Atrial Fibrillation Management and Outcomes (16 papers), Cardiac Arrhythmias and Treatments (8 papers) and Cardiovascular Function and Risk Factors (7 papers). Hiroaki Semba is often cited by papers focused on Atrial Fibrillation Management and Outcomes (16 papers), Cardiac Arrhythmias and Treatments (8 papers) and Cardiovascular Function and Risk Factors (7 papers). Hiroaki Semba collaborates with scholars based in Japan, China and United Kingdom. Hiroaki Semba's co-authors include Norihiko Takeda, Hajime Abe, Takeshi Yamashita, Tokuhisa Uejima, Yuko Kato, Shinya Suzuki, Junji Yajima, Takayuki Otsuka, Shunsuke Matsuno and Yuji Oikawa and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroaki Semba

42 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Semba Japan 10 234 126 83 59 56 45 531
Xianmin Meng China 16 288 1.2× 195 1.5× 85 1.0× 84 1.4× 50 0.9× 42 597
Qianyun Guo China 11 140 0.6× 180 1.4× 108 1.3× 94 1.6× 54 1.0× 31 511
Xuyu He China 11 310 1.3× 188 1.5× 87 1.0× 68 1.2× 43 0.8× 29 566
Mohammed Mamdani United States 12 165 0.7× 170 1.3× 88 1.1× 135 2.3× 63 1.1× 17 551
Chi‐Jen Chang Taiwan 15 186 0.8× 138 1.1× 91 1.1× 159 2.7× 61 1.1× 42 574
Yoshinori Mano Japan 13 189 0.8× 184 1.5× 41 0.5× 94 1.6× 52 0.9× 24 564
Ling Jie Wang China 13 150 0.6× 151 1.2× 49 0.6× 74 1.3× 39 0.7× 16 554
Zhaofei Wan China 14 207 0.9× 154 1.2× 52 0.6× 59 1.0× 36 0.6× 24 473
Joseph Pierre Aboumsallem Netherlands 15 336 1.4× 135 1.1× 72 0.9× 80 1.4× 49 0.9× 36 570

Countries citing papers authored by Hiroaki Semba

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Semba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Semba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Semba more than expected).

Fields of papers citing papers by Hiroaki Semba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Semba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Semba. The network helps show where Hiroaki Semba may publish in the future.

Co-authorship network of co-authors of Hiroaki Semba

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Semba. A scholar is included among the top collaborators of Hiroaki Semba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Semba. Hiroaki Semba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yagi, Naoharu, Shinya Suzuki, Takuto Arita, et al.. (2022). Association between serum alkaline phosphatase and cardiovascular events in patients with atrial fibrillation. Heart and Vessels. 38(2). 236–246. 1 indexed citations
3.
Nagai, Jun, Riho Kurata, Xiaofeng Cui, et al.. (2021). Establishment of Novel Protein Interaction Assays between Sin3 and REST Using Surface Plasmon Resonance and Time-Resolved Fluorescence Energy Transfer. International Journal of Molecular Sciences. 22(5). 2323–2323. 3 indexed citations
4.
Suzuki, Shinya, Takeshi Yamashita, Takayuki Otsuka, et al.. (2021). Identifying risk patterns in older adults with atrial fibrillation by hierarchical cluster analysis: A retrospective approach based on the risk probability for clinical events. IJC Heart & Vasculature. 37. 100883–100883. 9 indexed citations
5.
Nagai, Jun, Riho Kurata, Kenji Shimizu, et al.. (2020). Establishment of Novel High-Standard Chemiluminescent Assay for NTPase in Two Protozoans and Its High-Throughput Screening. Marine Drugs. 18(3). 161–161. 4 indexed citations
6.
Suzuki, Shinya, Hiroto Kano, Hiroaki Semba, et al.. (2020). Role of dipstick proteinuria for predicting cardiovascular events: a Japanese cardiovascular hospital database analysis. Heart and Vessels. 35(9). 1256–1269. 6 indexed citations
7.
Suzuki, Shinya, Takuto Arita, Naoharu Yagi, et al.. (2020). Decline in eGFR over time and incidence of cardiovascular events: Shinken database analysis. Journal of Cardiology. 77(6). 626–633. 4 indexed citations
8.
Suzuki, Shinya, Yuko Kato, Takuto Arita, et al.. (2020). Differences in treatment and prognosis by the experience of falls or bone fracture in elderly patients with atrial fibrillation. Heart and Vessels. 35(9). 1234–1242. 1 indexed citations
9.
Okada, Keita, Daisuke Mori, Hideki Nakamoto, et al.. (2020). Hypoxia-inducible factor-1 alpha maintains mouse articular cartilage through suppression of NF-κB signaling. Scientific Reports. 10(1). 5425–5425. 42 indexed citations
10.
Suzuki, Shinya, Takeshi Yamashita, Takuto Arita, et al.. (2019). Comparison of risk models for mortality and cardiovascular events between machine learning and conventional logistic regression analysis. PLoS ONE. 14(9). e0221911–e0221911. 47 indexed citations
11.
Sasaki, Kenichi, Hiroaki Semba, Yuko Kato, et al.. (2019). External suture annuloplasty for mild to moderate and moderate aortic regurgitation due to an isolated type Ic lesion. General Thoracic and Cardiovascular Surgery. 67(10). 855–860. 1 indexed citations
12.
Kano, Hiroto, Shinya Suzuki, Hiroaki Semba, et al.. (2019). Myocardial bridging is an independent predictor of positive spasm provocation testing by intracoronary ergonovine injections: a retrospective observational study. Heart and Vessels. 35(4). 474–486. 14 indexed citations
13.
Yagi, Naoharu, Shinya Suzuki, Takuto Arita, et al.. (2019). Creatinine clearance and inappropriate dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation. Heart and Vessels. 35(1). 110–117. 8 indexed citations
14.
15.
Abe, Hajime, Hiroaki Semba, & Norihiko Takeda. (2017). The Roles of Hypoxia Signaling in the Pathogenesis of Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis. 24(9). 884–894. 171 indexed citations
16.
Kato, Yuko, Shinya Suzuki, Tokuhisa Uejima, Hiroaki Semba, & Takeshi Yamashita. (2017). Variable prognostic value of blood pressure response to exercise. Journal of Cardiology. 71(1). 31–35. 2 indexed citations
17.
Kato, Yuko, Shinya Suzuki, Hiroaki Semba, et al.. (2016). THE RELATIONSHIP BETWEEN RESTING HEART RATE AND PEAK VO2: A COMPARISON OF ATRIAL FIBRILLATION AND SINUS RHYTHM. Journal of the American College of Cardiology. 67(13). 1640–1640. 2 indexed citations
18.
Kato, Yuko, Shinya Suzuki, Tokuhisa Uejima, et al.. (2016). Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation. Heart and Vessels. 32(4). 428–435. 6 indexed citations
19.
Saito, Tetsuya, Norihiko Takeda, Eisuke Amiya, et al.. (2013). VEGF‐A induces its negative regulator, soluble form of VEGFR‐1, by modulating its alternative splicing. FEBS Letters. 587(14). 2179–2185. 40 indexed citations
20.
Semba, Hiroaki, Koichiro Kinugawa, Norihiko Takeda, et al.. (2012). Preliminary Report of Tolvaptan Treatment in Japanese Patients With Heart Failure. International Heart Journal. 53(1). 72–74. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianmin Meng Breakdown of academic impact, for papers by Qianyun Guo Breakdown of academic impact, for papers by Xuyu He Breakdown of academic impact, for papers by Mohammed Mamdani Breakdown of academic impact, for papers by Chi‐Jen Chang Breakdown of academic impact, for papers by Yoshinori Mano Breakdown of academic impact, for papers by Ling Jie Wang Breakdown of academic impact, for papers by Zhaofei Wan Breakdown of academic impact, for papers by Joseph Pierre Aboumsallem
Rankless by CCL
2026